Skip to main content
. Author manuscript; available in PMC: 2010 Jan 7.
Published in final edited form as: Ann Intern Med. 2009 Jun 2;150(11):752–765. doi: 10.7326/0003-4819-150-11-200906020-00003

Table 2.

Mammography Recall Rates by Randomization Group, Stratified by Type of Hormone Therapy

Mammography recall by Study Group Relative Risk of Mammography
recall
Characteristics No-
suspension
n = 542
1-month
suspension
n = 478
2-months
suspension
n = 451
p-
Value
1-month vs.
No-suspension
2-month vs.
No-suspension
All study participants RR (95% CI) RR (95% CI)

  # recalled 61 59 44
  Recall rate (95% CI) 11.3 (8.7, 14.2) 12.3 (9.5,15.6) 9.8 (7.2, 12.9) .45 1.10 (0.78, 1.53) 0.87 (0.60, 1.25)

Estrogen only at baseline n = 335 n = 295 n = 286

  # recalled 31 34 24
  Recall rate (95% CI) 9.3 (6.1, 12.4) 11.5 (7.9, 15.2) 8.4 (5.2, 11.6) .42 1.25 (0.79, 1.97) 0.91 (0.55, 1.51)

Estrogen + progestin at baseline n = 207 n = 183 n = 165

  # recalled 30 25 20
  Recall rate (95% CI) 14.5 (9.7, 19.3) 13.7 (8.6, 18.7) 12.1 (7.1, 17.2) .80 0.94 (0.58, 1.54) 0.84 (0.49, 1.42)